Trends in Orthopedic Device Innovation: An Analysis of 510(k) Clearances and Premarket Approvals From 2000 to 2019
Authors:
- Collin W. BlackburnCBCollin W. Blackburn
- Joseph E. TanenbaumJTJoseph E. Tanenbaum
- Derrick M. KnapikDKDerrick M. Knapik
- James E. VoosJVJames E. Voos
- Robert J. GillespieRGRobert J. Gillespie
- Robert J. WetzelRWRobert J. Wetzel
- 1 March 2023
- journal article
- research article
- Published by SLACK, Inc. in Orthopedics
- Vol. 46 (2) , E98-+
Abstract
The objective of this study was to characterize recent trends in orthopedic device development across different subspecialty areas. Orthopedic 510(k) clearances, premarket approvals (PMAs; together, “authorizations”), and new market entrants from 2000 to 2019 were analyzed as markers of research and development activity. Data were extracted from the US Food and Drug Administration website and stratified into one of 9 “subspecialty” groups: spine, trauma, hip arthroplasty, knee arthroplasty, shoulder, hand/elbow, foot/ankle, cement/filler/graft, and other. Descriptive statistics were used to analyze the data. Growth rates were calculated from trailing 3-year averages. During the study period, there were 9906 orthopedic 510(k) clearances and 1409 PMAs, of which 61 were for original PMA submissions. The preponderance of 510(k) clearances were for devices used in spine (36%) and trauma (30%) surgery, followed by hip (11%) and knee (8%) arthroplasty. Annual 510(k) clearances for spine and trauma devices grew by 232% and 44%, respectively, whereas annual hip and knee arthroplasty clearances declined. Paralleling these findings, the influx of new manufacturers of orthopedic devices was greatest for the trauma surgery (438), spine surgery (383), and cement/filler/graft (181) markets. Spinal surgery and orthopedic trauma have become leading priorities in orthopedic product development during the past two decades. Meanwhile, hip and knee arthroplasty products have proportionally become a smaller category of new devices over time. These findings demonstrate changing priorities within orthopedic innovation. [ Orthopedics . 2023;46(2):e98–e104.]Keywords
This publication has 20 references indexed in Scilit:
- Drugs, Devices, and the FDA: Part 2JACC: Basic To Translational Science, 2016
- Analysis of FDA-Approved Orthopaedic Devices and Their RecallsJournal of Bone and Joint Surgery, 2016
- Variation in Costs of Spinal Implants in United States Academic Medical CentersSpine, 2016
- How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?Clinical Orthopaedics and Related Research, 2015
- Total Joint Arthroplasty: Trends in Medicare Reimbursement and Implant PricesThe Journal of Arthroplasty, 2014
- The 510(k) Ancestry of a Metal-on-Metal Hip ImplantNew England Journal of Medicine, 2013
- Spinal Fusion in the United StatesSpine, 2012
- Hospital Economics of Primary THA Decreasing Reimbursement and Increasing Cost, 1990 to 2008Clinical Orthopaedics and Related Research, 2011
- The operation of the century: total hip replacementThe Lancet, 2007
- ARTHROPLASTY OF THE HIP A New OperationThe Lancet, 1961